Could CareTrust (CTRE) Stock Be a Top Healthcare REIT as Acquisition Growth Accelerates?

CareTrust REIT (CTRE) experienced a surge in investor interest following impressive fiscal Q2 2026 earnings and updated full-year guidance. The healthcare REIT now anticipates normalized FFO per share of $2.03 to $2.06 for the year, aligning with the $2.03 analyst consensus. Q2 2026 saw total revenues jump 43% year-over-year to $161.34 million, with normalized FFO increasing 44% year-over-year to $119.7 million, or $0.51 per diluted share.

Net income soared to $89.0 million, or $0.38 per diluted share. This growth was fueled by a record $1.5 billion in investments with an average yield of 8.7%.

Despite the positive performance, Wall Street's reaction is mixed. RBC Capital analyst Michael Carroll downgraded CareTrust from Outperform to Sector Perform with a $43 price target. While acknowledging CTRE's capability to deploy capital efficiently, RBC shifted focus to competitors that can leverage strong fundamentals through organic growth.

The company's aggressive acquisition strategy has raised questions about whether the premium valuation justifies the reliance on external financing and market cap-rate compression. CTRE boasts a robust free cash flow that covers dividends and acquisitions, with net debt at 1.01x run-rate EBITDA, providing flexibility and minimal refinancing risk. High-spread deals, such as the recent $65 million Utah acquisition and $226 million international purchase, contribute to reliable FFO and FAD growth.

However, concerns include dependence on unsettled equity forward contracts, increasing competition in the SHOP segment leading to cap-rate compression, and uncertainties in long-term cash flow predictability due to material financing receivables. Hedge fund sentiment has become more favorable for CTRE, with a notable increase in positions held by funds like D. E. Shaw and Stuart J. Zimmer's Zimmer Partners.

Investors are advised to monitor the integration of recent acquisitions in the U.K. and Utah, SHOP underwriting cap rates, and the company's ability to maintain its deployment yield target without incurring excessive operator credit risk. While CTRE shows potential, some experts believe certain AI stocks may offer greater upside and lower downside risk.